Pharmaceutical and life sciences companies face a wide variety of third-party-related challenges such as compliance, pharmacovigilance, information security and more. Staying on top of emerging trends in the industry is critical to managing your TPRM programs. Join Aravo’s Kimberley Allan and David Rusher, as well as third
Did the pandemic act as a wake-up call for your organization to improve third party risk? You’re not alone, Deloitte’s sixth edition third-party risk management (TPRM) survey found that, ten months on, almost half of respondents were still reacting to the need for business continuity and resilience throughout their third-party ecosystem, digital capabilities and to manage third party relationships and risks in real time and responsibly.
So how can organizations better adapt to digital ways of working and technology, and manage a new breed of risks?
Join Mark Bethell and Dr. Sanjoy Sen of Deloitte as they discuss key findings from the survey: Gaining Ground: A Digital Path to third-party oversight, and offer expert insights into lessons learned and pathways forward.
In this interactive session, you’ll learn:
-Top and emerging risks you need to be on top of
-Practices you should be embedding in your program now to help you build a more resilient organization
-How technology supports greater risk management and resilience across the extended enterprise
Kimberley Allan
CMO
Dr. Sanjoy Sen
Head of Research, Extended Enterprise Risk Management Deloitte
Mark Bethell
Partner
Deloitte UK
